Found: 48
Select item for more details and to access through your institution.
Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRF<sup>HisGTG</sup> results in patients' poor treatment outcome.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1790, doi. 10.1111/bjh.19332
- By:
- Publication type:
- Article
28S rRNA-Derived Fragments Represent an Independent Molecular Predictor of Short-Term Relapse in Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 239, doi. 10.3390/ijms25010239
- By:
- Publication type:
- Article
miRNA-Based Technologies in Cancer Therapy.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 11, p. 1586, doi. 10.3390/jpm13111586
- By:
- Publication type:
- Article
Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9258, doi. 10.3390/ijms24119258
- By:
- Publication type:
- Article
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04034-5
- By:
- Publication type:
- Article
Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 4, p. 399, doi. 10.1093/clinchem/hvac218
- By:
- Publication type:
- Article
Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming.
- Published in:
- Journal of Translational Medicine, 2023, p. 1, doi. 10.1186/s12967-023-03935-9
- By:
- Publication type:
- Article
Epi‐miRNAs: Modern mediators of methylation status in human cancers.
- Published in:
- Wiley Interdisciplinary Reviews: RNA, 2023, v. 14, n. 2, p. 1, doi. 10.1002/wrna.1735
- By:
- Publication type:
- Article
Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2609, doi. 10.3390/ijms24032609
- By:
- Publication type:
- Article
First Trimester Maternal Plasma Aberrant miRNA Expression Associated with Spontaneous Preterm Birth.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14972, doi. 10.3390/ijms232314972
- By:
- Publication type:
- Article
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
- Published in:
- 2022
- By:
- Publication type:
- journal article
tRNA GlyGCC -Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 24, doi. 10.3390/cancers14010024
- By:
- Publication type:
- Article
Overexpression of the GR Riborepressor LncRNA GAS5 Results in Poor Treatment Response and Early Relapse in Childhood B-ALL.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6064, doi. 10.3390/cancers13236064
- By:
- Publication type:
- Article
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 13144, doi. 10.3390/ijms222313144
- By:
- Publication type:
- Article
P-059: miRNA profiling of CD138+ plasma cells identifies miR-181a-5p overexpression as independent predictor of short-term progression and poor treatment outcome in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S71, doi. 10.1016/S2152-2650(21)02193-5
- By:
- Publication type:
- Article
Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8498, doi. 10.3390/ijms22168498
- By:
- Publication type:
- Article
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3877, doi. 10.3390/cancers13153877
- By:
- Publication type:
- Article
Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2446, doi. 10.3390/cancers13102446
- By:
- Publication type:
- Article
Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1658, doi. 10.3390/cancers13071658
- By:
- Publication type:
- Article
Jagged Ends of Cell-Free DNA: Rebranding Fragmentomics in Modern Liquid Biopsy Diagnostics.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 4, p. 576, doi. 10.1093/clinchem/hvab036
- By:
- Publication type:
- Article
Impact of three-dimensional vision in laparoscopic partial nephrectomy for renal tumors.
- Published in:
- Turkish Journal of Urology, 2021, v. 47, n. 2, p. 144, doi. 10.5152/tud.2020.20439
- By:
- Publication type:
- Article
miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 12, p. 3560, doi. 10.1002/ijc.33182
- By:
- Publication type:
- Article
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5′-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment Outcome.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3661, doi. 10.3390/cancers12123661
- By:
- Publication type:
- Article
Circulating miR‐146a and miR‐134 in predicting drug‐resistant epilepsy in patients with focal impaired awareness seizures.
- Published in:
- Epilepsia (Series 4), 2020, v. 61, n. 5, p. 959, doi. 10.1111/epi.16502
- By:
- Publication type:
- Article
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
- Published in:
- Carcinogenesis, 2020, v. 41, n. 4, p. 442, doi. 10.1093/carcin/bgz163
- By:
- Publication type:
- Article
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 12, p. 3075, doi. 10.1007/s00432-019-03028-5
- By:
- Publication type:
- Article
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
- Published in:
- Carcinogenesis, 2019, v. 40, n. 8, p. 965, doi. 10.1093/carcin/bgz045
- By:
- Publication type:
- Article
HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0215984
- By:
- Publication type:
- Article
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1291, doi. 10.3390/ijms20061291
- By:
- Publication type:
- Article
The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.
- Published in:
- EMBO Reports, 2019, v. 20, n. 3, p. N.PAG, doi. 10.15252/embr.201846821
- By:
- Publication type:
- Article
Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 4, p. 937, doi. 10.3390/ijms20040937
- By:
- Publication type:
- Article
Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37856-1
- By:
- Publication type:
- Article
Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 12, p. 2104, doi. 10.1515/cclm-2018-0507
- By:
- Publication type:
- Article
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
miR‐221/222 cluster expression improves clinical stratification of non‐muscle invasive bladder cancer (TaT1) patients' risk for short‐term relapse and progression.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 3, p. 150, doi. 10.1002/gcc.22516
- By:
- Publication type:
- Article
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 4, p. 453, doi. 10.1007/s40291-017-0270-3
- By:
- Publication type:
- Article
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 3, p. 521, doi. 10.1007/s00432-016-2301-6
- By:
- Publication type:
- Article
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 11, p. 2023, doi. 10.1007/s00432-015-1982-6
- By:
- Publication type:
- Article
Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
- Published in:
- Carcinogenesis, 2015, v. 36, n. 5, p. 528, doi. 10.1093/carcin/bgv024
- By:
- Publication type:
- Article
A new tumor suppressor role for the Notch pathway in bladder cancer.
- Published in:
- Nature Medicine, 2014, v. 20, n. 10, p. 1199, doi. 10.1038/nm.3678
- By:
- Publication type:
- Article
Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients.
- Published in:
- Biological Chemistry, 2014, v. 395, n. 9, p. 1095, doi. 10.1515/hsz-2014-0150
- By:
- Publication type:
- Article
L-dopa decarboxylase ( DDC) gene expression is related to outcome in patients with prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 6b, p. E267, doi. 10.1111/j.1464-410X.2012.11152.x
- By:
- Publication type:
- Article
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
- Published in:
- Biological Chemistry, 2012, v. 393, n. 5, p. 301, doi. 10.1515/hsz-2011-0260
- By:
- Publication type:
- Article
Kallikrein-related peptidase 4 gene ( KLK4) in prostate tumors: Quantitative expression analysis and evaluation of its clinical significance.
- Published in:
- Prostate, 2011, v. 71, n. 16, p. 1780, doi. 10.1002/pros.21395
- By:
- Publication type:
- Article
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
- Published in:
- Biological Chemistry, 2010, v. 391, n. 5, p. 505, doi. 10.1515/BC.2010.056
- By:
- Publication type:
- Article
Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
- Published in:
- Cancer Science, 2010, v. 101, n. 3, p. 693, doi. 10.1111/j.1349-7006.2009.01450.x
- By:
- Publication type:
- Article